FADD and hepatocellular carcinoma: For instance, lncRNA H19 was found to decrease FADD levels by targeting miR-675 in GC, HCC, and liver necroptosis (Ge et al. 2019; Harari-Steinfeld et al. 2021; Yan et al. 2017).